Here we show that 12% of Dnmt3a-deficient mice develop CD8+ mature peripheral T cell lymphomas (PTCL) and 29% of mice are affected by both diseases. Here, DNMT3A is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.